Search

everythinglearnresearchcommunity

for

Search:↓

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

People with alopecia areata often have lower vitamin D levels than healthy people.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Oral Apremilast effectively treats alopecia areata in most patients.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Hair loss linked to higher heart disease risk in both men and women.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

New alopecia treatments aim for better results and fewer side effects.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Minoxidil with Korean red ginseng improves hair density and thickness more than minoxidil alone.

Balding and low testosterone increase risk of urinary stones.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.